Mycosis fungoides (MF) is an uncommon T-cell lymphoma which characteristically involves the skin. Two patients with MF are described who developed fatal complications secondary to involvement of the gastrointestinal tract. One developed malabsorption due to small intestinal involvement; the other had a massive haemorrhage from an ulcerated nodule of tumour in the stomach. The potential for extracutaneous spread is discussed, and it is emphasized that bowel infiltration should be considered in any patient with MF who develops gastrointestinal symptoms or complications.
Introduction
Mycosis fungoides (MF) is a rare type of malignant lymphoma derived from T cells (Zackheim 1981) . Clinically the disease presents in the skin and subsequently may undergo systemic dissemination. Although spread to the gastrointestinal tract has been described previously (Epstein et al. 1972 , Rappaport & Thomas 1974 , there have been few reports describing complications from this involvement. We report two patients with MF who developed fatal complications secondary to infiltration of the gastrointestinal tract.
Case reports
Case 1: A 48-year-old male driver presented in March 1974 with an itchy rash that had first started in 1966 on the sacrum and later spread to involve most of the body. Clinical examination showed an extensive erythematous eruption that was considered to be premycotic; this was confirmed by skin biopsy. There was no lymphadenopathy or hepatosplenomegaly and the haemoglobin, white cell count (WCC) and erythrocyte sedimentation rate (ESR) were normal.
Treatment was started with topical fluocinolone acetonide. Nodules developed on the right forearm in 1975 and a skin biopsy at that time showed MF. Histological features included a band-like infiltrate of lymphoid cells in the dermis with extension into the epidermis (Figure 1 ). Both small and large mycosis cells were present, with the former type predominating. Electron microscopy showed the characteristic morphology of mycosis cells with cerebriform nuclei (Figure 2 ). The patient was referred for strontium-90 whole-body irradiation: he received a total of 3120 rad, and there was regression of the skin lesions. The skin nodules recurred in June 1976 and treatment was altered to cyclophosphamide and prednisolone. During the following year infiltrated plaques developed on the face, trunk and limbs, and in January 1978 photochemotherapy was started with oral 8-methoxypsoralen and long-wave ultraviolet light (PUVA treatment). By June 1978, after 20 treatments and a total dose of 63 J/cm2, there was complete resolution of all skin lesions. During the next year PUVA-treatment was continued, but due to poor attendance only 35 treatments. and a total dose of 115 J/cm2 were given. Maintenance chemotherapy with cyclophosphamide and prednisolone was continued and the haemoglobin, WCC and ESR remained normal. Following an episode of severe vomiting in August 1978, a barium meal and followthrough examination was performed: no radiological abnormalities were detected. The small bowel transit time was considered to lie within the normal range. In November 1979 the patient suffered marked clinical deterioration, with a weight loss of 10 kg over 8 weeks and the development of diarrhoea. The motions, 9-12 times per day, were described as being loose, bulky, cream-coloured and difficult to flush away. There was no associated abdominal pain. The motions were not blood-stained, and treatment with codeine phosphate was ineffective. Clinical examination showed left inguinal lymphadenopathy but no evidence of hepatosplenomegaly.
Investigations showed a normal haemoglobin concentration (13.2 g/dl) but an elevated ESR (90 mm/h, Westergren). The WCC was low (5.2 x 109/l) with a relative lymphopenia but a normal distribution of lymphocyte subpopulations (T cells 68%, B cells 9%). The serum iron (4.0 pmol/l), serum B12 (132 ng/l), serum folate (0.4 jg/l), red cell folate (135 Mg/l), plasma potassium (2.9 mmol/l) and serum albumin (31 g/l) were all low. The serum alkaline phosphatase was slightly elevated (121 U/l) but the total protein concentration, serum transaminases, plasma urea, corrected plasma calcium, plasma phospate, immunoglobulins and the prothrombin time were normal. No pathogens were isolated on culture of the faeces and the clinical impression of malabsorption was supported by an abnormal xylose excretion test (uri-nary excretion of xylose 5 mmol in 5 hours following an oral dose of 167 mmol). The presence of steatorrhoea was demonstrated by an elevated faecal fat excretion (average excretion 54 mmol/day as stearic acid).
A barium meal and follow-through examination showed abnormalities in the jejunum and ileum that included widening and stiffening of the mucosal folds and flocculation of the barium (Figure 3 ). Compared to the first follow-through examination, the transit time was considerably prolonged. A lymphangiogram showed that the lymph nodes in the left inguinal area and in the left external and internal iliac chains were expanded with an abnormal architecture. The lymph nodes on the right side and in the para-aortic area were radiologically normal. A large bowel double contrast barium enema and a radioisotope scan of the liver and spleen were normal.
A jejunal biopsy showed mild partial villous atrophy with crypt hyperplasia (Figure 4 ). The surface cells remained columnar with a prominent brush border. The lamina propria showed an increased cellular infiltrate and many of the cells were atypical, with either small or large cerebriform nuclei ( Figure 5 ). The morphology of the cells was similar to that seen previously in the skin, although increased numbers of the larger mycosis cells were present. Intraepithelial cells present were of a similar nature. Biopsy of the lymph node in the groin showed effacement of the architecture by a lymphoid infiltrate identical to that in the bowel. Immunoperoxidase studies on the paraffin-embedded jejunal and node biopsies showed no evidence of cytoplasmic immunoglobulin production, and markers for histiocytic differentiation (lysozyme and alpha 1-antitrypsin) were negative.
Because of the systemic spread, cyclical chemotherapy (cyclophosphamide, vincristine, adriamycin and prednisolone) was started in February 1980. After six courses the diarrhoea had subsided, the patient felt symptomatically better and the faecal fat excretion and plasma potassium had returned to normal. However, in January 1981 the steatorrhoea and infiltrative skin lesions recurred and hepatomegaly developed. The patient rapidly deteriorated and died. Permission for an autopsy was declined.
Case 2: A 63-year-old metal worker presented in October 1977 with an itchy skin rash. This had first started on the back two months previously and later became more widespread. In 1975 he had been found to be hypertensive and was being treated with methyldopa.
Examination showed a widespread infiltrated erythematous macular eruption with several scalpy plaques on the trunk. There was no evidence of lymphadenopathy or hepatosplenomegaly, and the blood pressure was 190/120 mmHg. Investigations showed a normal haemoglobin, WCC, platelet count, serum iron and total iron-binding capacity, serum immunoglobulins and chest X-ray. The ESR was elevated (55 mm/h Westergren). A skin biopsy showed a superficial lichenoid mononuclear cell infiltrate; in the absence of atypical cells, it was uncertain whether the rash represented a reaction to methyldopa or was a premycotic eruption. He was treated with betamethasone valerate (0.025%) ointment and the methyldopa was changed to oxyprenolol. Within two weeks he had improved and his itching was much less. In August 1979 clinical deterioration was apparent, with marked loss of weight (over 19 kg), and he had developed numerous infiltrated lesions on the trunk, limbs, eyelids, hands and feet; many of these were ulcerated and infected. He had a low-grade pyrexia and there was bilateral lymphadenopathy in the axillae and groins. There was no hepatosplenomegaly.
Investigations showed a normal haemoglobin and WCC. Of the circulating lymphocytes, 8% were B cells and 61% were T cells. Occasional mycosis cells were present in the peripheral blood and in a bone marrow aspirate. The ESR (135 mm/h), plasma IgG (23.3 g/l), IgA (3.9 g/l), IgE (889 U/I), alanine transaminase (60 U/1), aspirate transaminase (55 U/l), alkaline phosphatase (196 U/1), gammaglutamyl transferase (182 U/l), and globulin (42 g/l) were all raised. The plasma albumin (31 g/l) was lowered. The plasma urea, electrolytes, IgM, serum iron, total iron binding capacity, B12 and folate were all normal. A chest X-ray and technetium-99m liver and spleen scan were also normal. A lymphangiogram could not be performed due to infected lesions on the feet. Culture of the infected lesions grew Staphylococcus pyogenes and a beta-haemolytic Streptococcus. A blood culture was negative. The skin biopsy now showed the typical histological features of MF, similar to those in Case 1.
PUVA treatment was started in September 1979, initially 3 times a week and later once weekly. Over the next two years photochemotherapy was continued, but lesions developed in so-called 'sanctuary areas' around the eyes, the soles of the feet, medial aspect of the upper thighs, and axillae. These were areas that were not being sufficiently irradiated by the long-wave ultraviolet light and were treated with local X-rays and/or topical nitrogen mustard. Further improvement occurred in November 1980 following the use of oral triamcinolone. Intermittent secondary infection of the lesions still occurred, requiring both topical and systemic antibiotics. Between August and October 1981 his skin lesions were more resistant to treatment and there were episodes of nocturnal epigastric pain. He was also dyspnoeic on exertion.
Investigations showed that the haemoglobin had fallen to 7.8 g/dl, with a low mean corpuscular haemoglobin (25 pg), low mean corpuscular haemoglobin concentration (28 g/dl) and low serum iron (5 pimol/1). The WCC, platelet count, total iron-binding capacity and mean corpuscular volume were normal. The reticulocyte count was slightly raised (3%). A chest X-ray ( Figure 6 ) showed that bilateral multiple round opacities had developed in the lung fields.
Unfortunately, before further investigations or systemic chemotherapy could be instituted, the patient suddenly collapsed and died.
Autopsy showed that death was due to a massive gastrointestinal haemorrhage from an 8 cm ulcer in the gastric cardia. Histology revealed that the ulcer had arisen in a deposit of MF (Figure 7) . The infiltrate included both small and large cerebriform mycosis cells. Immunoperoxidase studies on paraffin-embedded tumour tissue showed an absence of cytoplasmic immunoglobulins and no evidence of histiocytic differentiation. Multiple mycotic nodules were also present in the lungs, liver and lymph nodes. 
Discussion
It is now well established that MF can undergo systemic spread, and occasional studies have shown involvement ofthe gastrointestinal tract. Epstein et al. (1972) reported on 86 fatal cases of MF in which autopsies had been performed: gastric and small intestinal involvement were seen in 7 and 13 patients respectively. Those findings were confirmed by Rappaport & Thomas (1974) who reviewed autopsy material from 45 cases of MF. Excutaneous involvement was found in 32 patients (71%), the stomach being involved in 4 and the intestine in 6. As emphasized in these autopsy studies, and illustrated by both of our cases, systemic spread of MF often follows or is associated with lymphadenopathy due to nodal involvement. The nodular, bilateral pattern of pulmonary infiltration seen in the second case is similar to that described by Wolfe et al. (1980) . As discussed in detail elsewhere (Slater 1984 , Gazdar et al. 1979 , there is now increasing evidence that cutaneous T-cell lymphoma is associated with a new C-type retrovirus: human Tcell leukaemia/lymphoma virus. Early stages of the disease appear to represent a complex immunological interaction between T4 (helper) lymphocytes and antigenically-stimulated Langerhans' cells migrating between the skin and associated lymph nodes (Slater 1984) . Dissemination ofthe disease beyond these initial sites appears to occur at a later stage as the T cells alter to an immature phenotype (Slater 1984) .
When MF spreads systemically, there is a tendency for the cellular infiltrate to become more pleomorphic (Schmoeckel et al. 1981) . This was observed in both ofour cases and correlates with the development ofan immature phenotype, as already discussed. Originally this was considered to represent transitional Hodgkin's disease or histiocytic lymphoma (Cyr et al. 1966) . However, there is now general agreement that this change represents immunoblastic transformation ofthe T cells (Lennert 1981) . Modern techniques used to identify T lymphocytes include monoclonal antibody studies (Chu et al. 1982 ) and histochemical investigations for acid phosphatase and nonspecific esterase (Chu et al. 1981) . However, the techniques should be performed on cryostat sections, and enzyme activity is frequently absent from neoplastic Tcells. Unfortunately, suitable tissue was not available from our two cases to perform such investigations.
However, as emphasized by Rappaport & Thomas (1974) , the presence of mycosis cells in cellular infiltrates is still regarded as an indispensable aid in the histological diagnosis of MF. In addition, the absence of cytoplasmic immunoglobulins, lysozyme and alpha-I -antitrypsin from the tumour cells in our patients strongly supported the view that the gastrointestinal malignancies represented mycotic dissemination. Monoclonal antibody studies on other patients who have died from systemic MF with immunoblastic transformation have shown that the cells can still retain their T4 phenotype (Slater, unpublished observations) . When Hodgkin's disease and non-Hodgkin's malignant lymphoma involve the gastrointestinal tract, clinical manifestations are well recognized. These include haemorrhage, obstruction, perforation and malabsorption (Ehrlich et al. 1968 , Eidelman et al. 1966 . It is perhaps surprising, therefore, that such complications have not been reported more frequently with MF.
Castleman & McNeely (1971) have described a patient with MFwho, as in our second case, died following haemorrhage from a tumour nodule in the stomach. A similar case was also reported by Cyr et al. (1966) but systemic spread in their patient, as already discussed, was considered to represent the secondary development of Hodgkin's disease. A recent report by Camisa & Goldstein (1981) described a patient with MF who died following perforation of small bowel infiltrated by lymphoma. However, this patient gave no previous history of gastrointestinal symptoms. There appears to be no previous report of malabsorption due to small intestinal infiltration by MF. The only comparable case is that reported by Cohen et al. (1977) in which a patient with the Sezary syndrome developed diarrhoea (but not malabsorption) due to infiltration of the small bowel. However, this is of interest as MF and the Sezary syndrome are considered to be members of the same group of cutaneous T-cell lymphomas.
The possibility that Case I had coeliac disease with secondary infiltration by MF was carefully considered. However, this was thought to be unlikely as the development of malabsorption appeared to parallel mycotic dissemination; in addition, malabsorption was corrected by chemotherapy but returned at the time of further systemic spread.
